Literature DB >> 34302647

Fabrication of Cardiac Constructs Using Bio-3D Printer.

Kenichi Arai1, Daiki Murata1, Shoko Takao1, Koichi Nakayama2.   

Abstract

The fabrication of three-dimensional (3D) cardiac tissue using human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is useful not only for regenerative medicine, but also for drug discovery. Here, we report a bio-3D printer that can fabricate tubular cardiac constructs using only human iPSC-CMs. Protocols to evaluate the contractile force and response to electrical stimulation in the cardiac constructs are described. We confirmed that the constructs can be applied for transplantation or drug response testing. In the near future, we expect that the constructs will be used as alternatives for heart transplantation and in animal experiments for new drug development.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bio-3D printer; Biofabrication; Cardiac construct; Human induced pluripotent stem cell-derived cardiomyocytes; Scaffold-free

Year:  2021        PMID: 34302647     DOI: 10.1007/978-1-0716-1484-6_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Bioink Formulation and Machine Learning-Empowered Bioprinting Optimization.

Authors:  Sebastian Freeman; Stefano Calabro; Roma Williams; Sha Jin; Kaiming Ye
Journal:  Front Bioeng Biotechnol       Date:  2022-06-13

2.  Scaffold-Free Tubular Engineered Heart Tissue From Human Induced Pluripotent Stem Cells Using Bio-3D Printing Technology in vivo.

Authors:  Yujiro Kawai; Shugo Tohyama; Kenichi Arai; Tadashi Tamura; Yusuke Soma; Keiichi Fukuda; Hideyuki Shimizu; Koichi Nakayama; Eiji Kobayashi
Journal:  Front Cardiovasc Med       Date:  2022-01-20

Review 3.  Taking It Personally: 3D Bioprinting a Patient-Specific Cardiac Patch for the Treatment of Heart Failure.

Authors:  Niina Matthews; Berto Pandolfo; Daniel Moses; Carmine Gentile
Journal:  Bioengineering (Basel)       Date:  2022-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.